BioSpace News Archive

BioMidwest

Gravie announces a new ICHRA solution for businesses following new 2020 regulations that allow for company-funded, tax-advantaged contributions to individual HRA plans

Minneapolis-based health insurance marketplace and benefits partner, Gravie, is announcing an individual coverage health reimbursement arrangement (ICHRA) solution in the wake of newly issued regulations

October 11, 2019
·
3 min read
Business

LeMaitre Vascular Will Announce Third Quarter 2019 Earnings Results on October 23, 2019

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2019 financial results on Wednesday, October 23, 2019, after the market close.

October 11, 2019
·
1 min read
Lilly’s REYVOW™ (lasmiditan), The First and Only Medicine in a New Class of Acute Treatment for Migraine, Receives FDA Approval

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of migraine, with or without aura, in adults

October 11, 2019
·
11 min read
Biotech Beach

Turn Therapeutics™ Announces FDA Clearance of Protego™ Antimicrobial Wound Dressing

Turn Therapeutics™, Inc., a Los Angeles-based pharmaceutical and medical device company, has announced FDA clearance of Protego™ Antimicrobial Wound Dressing, an important and disruptive innovation to traditional petroleum saturated gauze dressings.

October 11, 2019
·
2 min read
Business

Marizyme, Inc., Agrees to Distribute Somahlution’s DuraGraft Products in South America and Mexico

Marizyme, Inc., a publicly traded company focused on acquiring late-stage drug assets to develop for use in the acute care space, announced that they have agreed to exclusively distribute Somahlution’s DuraGraft® products in Mexico and South America.

October 11, 2019
·
4 min read
Policy

Information Update - Health Canada warns of potential risk of pulmonary illness associated with vaping products - Oct. 11, 2019

Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness and to seek medical attention promptly if they have concerns about their health..

October 11, 2019
·
5 min read
Policy

Advisory - Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes

Consumers and pharmacists should check that devices can be removed from their carrier tubes with ease

October 11, 2019
·
4 min read
Tesamorelin Study Results on NAFLD Published in Lancet HIV

Theratechnologies Inc. is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health on the effects of tesamorelin on Non-alcoholic Fatty Liver Disease in HIV were published in the Lancet HIV.

October 11, 2019
·
5 min read
Drug Development

Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

Zero anti-VEGF rescue injections required in the first cohort and durable efficacy with median follow up of 34 weeks

October 11, 2019
·
12 min read
Drug Development

Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration

Two-year results from CEDAR and SEQUOIA demonstrate that vision gains observed after one year with every 8-week and every 12-week dosing were maintained in the second year

October 11, 2019
·
7 min read